Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
AstraZeneca insists Celgene deal about strategy, not cash
Yahoo/Reuters
Fri, 04/24/15 - 09:24 am
AstraZeneca
Celgene
cancer immunotherapy
MEDI4736
Pfizer's Once And Future Deals
Seeking Alpha
Fri, 04/24/15 - 09:23 am
Pfizer
M&A
Hospira
AstraZeneca
AstraZeneca profit falls as patent expires on heartburn drug
Yahoo/AP
Fri, 04/24/15 - 09:21 am
AstraZeneca
earnings
Nexium
Juno teams with AstraZeneca to explore new therapy, foot the bill for clinical trial
Bizjournals.com
Thu, 04/23/15 - 07:58 pm
Juno Therapeutics
AstraZeneca
cancer immunotherapy
Psychiatrists With Ties to AstraZeneca Resign From Texas State Hospital
WSJ Pharmalot
Tue, 04/21/15 - 12:15 pm
AstraZeneca
psychiatrists
physicians
Seroquel XR
4 Big Biopharma Deals We Might See In 2015
Seeking Alpha
Fri, 04/17/15 - 08:42 am
AbbVie
AstraZeneca
Biomarin
Bristol-Myers Squibb
Celgene
Gilead Sciences
GSK
Hospira
Jazz Pharmaceuticals
Merck
Seattle Genetics
Shire
AstraZeneca lung cancer drug delays disease by more than a year
Yahoo/Reuters
Fri, 04/17/15 - 08:37 am
AstraZeneca
AZD9291
lung cancer
AstraZeneca immune system drug wins orphan status in rare cancer
Yahoo/Reuters
Wed, 04/15/15 - 10:25 am
AstraZeneca
tremelimumab
mesothelioma
AstraZeneca science is on the move, one year on from Pfizer bid
Yahoo/Reuters
Wed, 04/15/15 - 10:23 am
AstraZeneca
Pfizer
Onglyza's label should flag heart failure risks, FDA panel says
Fierce Pharma
Wed, 04/15/15 - 08:49 am
Onglya
diabetes
FDA
AstraZeneca
AstraZeneca taps PatientsLikeMe's network for drug R&D insights
Fierce Biotech
Tue, 04/14/15 - 12:28 pm
AstraZeneca
patients
R&D
Safety scare with AstraZeneca's diabetes drug could shake up the DPP-4 field
Fierce Biotech
Fri, 04/10/15 - 03:54 pm
AstraZeneca
Onglyza
diabetes
DPP-4 inhibitor
Takeda
Merck
Nesina
Januvia
FDA: Data suggests AstraZeneca drug may increase death rate
Yahoo/Reuters
Fri, 04/10/15 - 10:44 am
AstraZeneca
FDA
Onglyza
diabetes
AZ's Onglyza has most to lose at FDA safety confab, analysts say
Fierce Pharma
Thu, 04/9/15 - 11:52 am
FDA
Onglyza
diabetes
AstraZeneca
FDA Onglyza panel review set for Tuesday
Medical Marketing and Media
Wed, 04/8/15 - 05:19 pm
FDA
advisory panels
Onglyza
diabetes
AstraZeneca
The largest biopharma layoffs of 2014
Fierce Pharma
Tue, 04/7/15 - 11:10 am
layoffs
Amgen
Novartis
Allergan
GSK
Boehringer Ingelheim
Actavis
AstraZeneca
10 Largest Companies by Market Cap in Pharmaceuticals
Motley Fool
Mon, 04/6/15 - 05:37 pm
JNJ
Novartis
Pfizer
Merck
Sanofi
GSK
Bristol-Myers Squibb
AbbVie
AstraZeneca
Eli Lilly
AstraZeneca buys into Harvard's stem cell tech for diabetes R&D
Fierce Biotech
Thu, 03/26/15 - 09:37 am
AstraZeneca
Harvard
stem cells
diabetes
R&D
Psoriasis data wars heat up at AAD with Novartis, Boehringer studies
Fierce Pharma Marketing
Thu, 03/26/15 - 07:38 am
Novartis
psoriasis
Boehringer Ingelheim
Pfizer
Xeljanz
Cosentyx
JNJ
Stelara
BI-655066
Amgen
AstraZeneca
Merck
Eli Lilly
AstraZeneca to Disclose Trial Data, but how Independent is its Review Panel?
WSJ Pharmalot
Wed, 03/25/15 - 08:51 am
clinical trials
AstraZeneca
clinical trial data
Pages
« first
‹ previous
…
85
86
87
88
89
90
91
92
93
…
next ›
last »